celecoxib has been researched along with colforsin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Breyer, RM; Dannenberg, AJ; Du, B; Falcone, DJ; Khan, KM; Natarajan, C; Pavlovic, S; Sakamoto, K | 1 |
Abo-Elmatty, DM; Ahmed, AA; El-Baz, AA; Mosaad, SM; Moustafa, YM; Zaitone, SA | 1 |
2 other study(ies) available for celecoxib and colforsin
Article | Year |
---|---|
Targeting prostaglandin E2 receptors as an alternative strategy to block cyclooxygenase-2-dependent extracellular matrix-induced matrix metalloproteinase-9 expression by macrophages.
Topics: Animals; Blotting, Western; Bucladesine; Celecoxib; Cell Line; Colforsin; Cyclooxygenase 2; Extracellular Matrix; Gene Silencing; Macrophages; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Naphthalenes; Oligonucleotides; Peritoneum; Phenylbutyrates; Phosphorylation; Pyrazoles; Receptors, Prostaglandin E; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Sulfonamides; Time Factors; Transfection | 2006 |
Evening primrose oil or forskolin ameliorates celecoxib-enhanced upregulation of tissue factor expression in mice subjected to lipopolysaccharide-induced endotoxemia.
Topics: Animals; Antithrombin III; Blood Coagulation; Celecoxib; Colforsin; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Endotoxemia; Fibrinolytic Agents; gamma-Linolenic Acid; Linoleic Acids; Lipopolysaccharides; Lung; Male; Mice; Oenothera biennis; Peptide Hydrolases; Plant Oils; Thromboplastin; Thrombosis; Up-Regulation | 2017 |